Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve Board meeting to ....
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs & Organics has called a Board meeting on February 6, 2026. Three key items are on the agenda: (1) noting the resignation of Independent Director Shri Rukmesh P. Dhandhania effective January 16, 2026; (2) approving the appointment of Mr. Jeevan Mukund Dalvi as the new Chief Financial Officer effective February 6, 2026; and (3) re-appointing Dr. Praveen Saxena as Non-Executive Independent Director for a second 5-year term running from March 21, 2026 to March 20, 2031. The meeting will be held at the company's registered office in Mumbai.
No immediate financial impact on shareholders, but the CFO change and director reshuffle signal leadership transition. The new CFO appointment and continuity of an independent director should be viewed as routine governance updates.